Table of contents

Extended reports

• Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors (26 August, 2004)

  T R D J Radstake, R van der Voort, M ten Brummelhuis, M de Waal Malefijt, M Looman, C G Figdor, W B van den Berg, P Barrera, G J Adema
• Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with rheumatoid arthritis (14 October, 2004)

  P L E M van Lent, P N Span, A W Sloetjes, T R D J Radstake, A W T van Lieshout, J J T M Heuvel, C G J Sweep, W B van den Berg
• Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography (11 February, 2005)

  E Naredo, G Bonilla, F Gamero, J Uson, L Carmona, A Laffon
• Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement (11 February, 2005)

  A Del Rosso, O Distler, A F Milia, C Emanueli, L Ibba-Manneschi, S Guiducci, M L Conforti, S Generini, A Pignone, S Gay, P Madeddu, M Matucci-Cerinic
• Effect of nitric oxide on mitochondrial respiratory activity of human articular chondrocytes (11 February, 2005)

  E Maneiro, M J López-Armada, M C de Andres, B Caramés, M A Martín, A Bonilla, P del Hoyo, F Galdo, J Arenas, F J Blanco
• Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis (22 July, 2004)

  A Boonen, R van den Heuvel, A van Tubergen, M Goossens, J L Severens, D van der Heijde, S van der Linden
• Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNFα (5 August, 2004)

  C Eriksson, S Engstrand, K-G Sundqvist, S Rantapää-Dahlqvist
• Inhibition of TNFα during maturation of dendritic cells results in the development of semi-mature cells: a potential mechanism for the beneficial effects of TNFα blockade in rheumatoid arthritis (15 July, 2004)

  A W T van Lieshout, P Barrera, R L Smeets, G J Pesman, P L C M van Riel, W B van den Berg, T R D J Radstake
• Effect of treatment of rheumatoid arthritis with infliximab on IFNγ, IL4, T-bet, and GATA-3 expression: link with improvement of systemic inflammation and disease activity (29 July, 2004)

  M Kawashima, P Miossec
• Galectin-3 is induced in rheumatoid arthritis synovial fibroblasts after adhesion to cartilage oligomeric matrix protein (2 September, 2004)

  M Neidhart, F Zaucke, R von Knoch, A Jüngel, B A Michel, R E Gay, S Gay
• Lower limb arterial incompressibility and obstruction in rheumatoid arthritis (22 July, 2004)

  I del Rincón, R W Haas, S Pogosian, A Escalante
• Decreased prolactin response to hypoglycaemia in patients with rheumatoid arthritis: correlation with disease activity (19 August, 2004)

  A M M Eijsbouts, F H J van den Hoogen, R F J M Laan, C G J Sweep, A R M M Hermus, L B A van de Putte
• Evidence for familial aggregation of hand, hip, and spine but not knee osteoarthritis in siblings with multiple joint involvement: the GARP study (30 September, 2004)

  N Riyazi, I Meulenbelt, H M Kroon, K H Ronday, M-P Hellio le Graverand, F R Rosendaal, F C Breedveld, P E Slagboom, M Kloppenburg
• Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus (29 July, 2004)

  N Marto, M L Bertolaccini, E Calabuig, G R V Hughes, M A Khamashta
• A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis (2 September, 2004)

  L S Lohmander, D McKeith, O Svensson, M Malmenäs, L Bolin, A Kalla, G Genti, J Szechinski, C Ramos-Remus
• Distinct tumour necrosis factor α, interferon γ, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener’s granulomatosis (11 February, 2005)

  B M Spriewald, O Witzke, R Wassmuth, R R Wenzel, M-L Arnold, T Philipp, J R Kalden
• Pathogenic role of anti-β2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of β2-glycoprotein I binding to trophoblast cells and functional effects of anti-β2-glycoprotein I antibodies in vitro (15 July, 2004)

  N Di Simone, E Raschi, C Testoni, R Castellani, M D’Asta, T Shi, S A Krilis, A Caruso, P L Meroni